Osteoarthritis Trial, Recruiting NCT07248072 Sponsor: Ataturk University Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT07248072
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 75 years of age
  • People who are scheduled for a planned, first-time knee replacement surgery on one knee
  • People whose surgery is planned to use spinal anaesthesia (numbing the lower body rather than general anaesthesia)
  • People whose overall health status falls within a certain accepted range as assessed by their doctor (a standard health classification system used before surgery)
  • People who are able to understand what the study involves and sign a consent form agreeing to take part

Who may not be able to join:

  • People with a known allergy or sensitivity to local anaesthetic medicines or other medications used in the study
  • People who have blood clotting problems or who are currently taking blood-thinning medications
  • People with severe liver, kidney, or heart failure
  • People with a history of nerve pain conditions
  • People who have an infection at or near the area where a nerve block injection would be given
  • People who already have a nerve or muscle condition affecting their legs
  • People who are unable or unwilling to cooperate with the study requirements
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ahmet Murat Yayık, Principal Investigator, Ataturk University Department of Anesthesiology and Reanimation

Phone: +90-554-425-92-87

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ataturk University
Registry
ClinicalTrials.gov
Start date
1 December 2025
Est. completion
1 July 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Quality of Recovery-15 (QoR-15) Score at 24 Hours

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov